It was also demonstrated that the blockade of MEK/ERK signaling induced depression-like behavior in mice and blocked or reduced the antidepressant-like effects of desipramine and sertraline in FST [47], and that imipramine averted the disruption in MEK/ERK signaling induced by restraint stress in mice [44]. The gene discussed is MAP2K7; the disease is depressive symptom measurement.